First paper of the MODE study out today! We explored how interim non-cancer diagnoses might impact cancer diagnoses from the view point of HCPs, patients, and in terms of cost, time to diagnosis and disease stage. This first paper describes our HCP interview findings. Lots more to come soon!

BJGP@bjgp.org · last mo.

Consistent safety-netting is required to ensure timely review of non-cancer ‘interim’ diagnoses when there is a possible underlying #Cancer diagnosis doi.org/10.3399/BJGP... @clairefriedsmith.bsky.social @exeter.ac.uk @oxprimarycare.bsky.social @qmul-wiph.bsky.social #PrimaryCare #GeneralPractice

Had a great time at the RCC winter conference yesterday, thanks so much for the invite! #RCCAGM2026 www.instagram.com/p/DUIlKdsFXz...

Royal College of Chiropractors on Instagram: "AGM 2026 Speaker countdown! #RCCAGM2026 What lessons could be learnt from general practice research in regards to uncertainty and patient safety? Dr Clai...

3 likes, 0 comments - royalcollegeofchiropractors on January 30, 2026: "AGM 2026 Speaker countdown! #RCCAGM2026 What lessons could be learnt from general practice research in regards to uncertainty a...

instagram.com

A brilliant paper from my brilliant friend, colleague and desk buddy, Kiana Collins. PSA testing may not be being received by those who are most likely to benefit, and may be overused in those less likely to benefit.

The BMJ@bmj.com · 10mo ago

New BMJ Research: Current prostate specific antigen testing “may not effectively target testing to those most likely to benefit, raising concerns about overtesting” warn researchers from @ox.ac.uk in a study of over 10 million men across England www.bmj.com/content/391/...

🆕 Patients with vague symptoms like fatigue or unexplained weight loss get faster referrals & earlier cancer diagnoses via the SCAN Pathway, finds 6-year evaluation of 4,800+ patients. @oxfordcancer.bsky.social @lancetprimarycare.bsky.social @oxfordbrc.bsky.social @clairefriedsmith.bsky.social

Faster cancer diagnosis pathway for patients with non-specific symptoms evaluated in major study

A major new study led by researchers at the Nuffield Department of Primary Care Health Sciences has provided the most comprehensive analysis to date of the SCAN Pathway, a referral route which aims to...

phc.ox.ac.uk

Very excited to be able to share our paper detailing the findings of the SCAN Pathway, a non-specific symptoms for cancer pathway, which is out today in The Lancet Primary Care www.thelancet.com/journals/lan... @oxprimarycare.bsky.social @lancetprimarycare.bsky.social @oxfordcancer.bsky.social

Patient characteristics, serious disease diagnoses, and incidental findings in individuals with non-specific symptoms referred to the Suspected CANcer (SCAN) Pathway: a prospective cohort study in Eng...

CT-led non-specific symptom pathways can identify a relatively high proportion of patients with cancers that are harder to diagnose, but also a similar proportion of patients with an incidental findin...

thelancet.com

In a world where GP is bashed, a lot, @timsenior.bsky.social finds the value bjgp.org/content/75/7... This line in particular got me: The consultations I have had with these patients aren’t consultations of 15 or 30 minutes. They are consultations of 2, 5, 10 years, split up into 15-minute chunks.

Good bye sunny Manchester and the always brilliant #CaPRI2025. Already looking forward to next year.

Ever used the Aarhus Statement in your cancer in primary care research? I'm pleased to be part of the team aiming to update it, if you are asked to complete the Delphi please do consider contributing and stay tuned! #CaPRI2025

Truly fascinating and sobering keynote talk from Prof Richard Sullivan to kick off #CaPRI2025 on the future of global cancer care. Global public health is changing, hopefully for the better but the challenge is enormous.

Hi Bluesky! So excited to be in Manchester for the #CaPRI2025 cancer in primary care conference